CT and 3-T MRI accurately identify T3c disease in colon cancer, which strongly predicts disease-free survival

T3c or greater disease is the strongest risk factor for predicting DFS in colon cancer, and is accurately identified on imaging. T3c+ disease may therefore be the best imaging entry criteria for trials of neoadjuvant treatment.